Matthias Rischer
10Patents
5h-index
22Co-inventors
66Inventor score
Filing activity: Feb 12, 1997 → Feb 18, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5914425A | Modifications of 2-amino-4-(4-5fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation | Human Necessities | 22 | Expired |
| US6538151B1 | Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation | Human Necessities | 14 | Expired |
| US7214662B2 | Injectable solution of an LHRH antagonist | Human Necessities | 13 | Expired |
| US5990152A | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | Human Necessities | 7 | Expired |
| US6348490B1 | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | Human Necessities | 5 | Expired |
| US7871977B2 | Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments | Human Necessities | 5 | Active |
| US5994393A | Alpha-lipoic acid with novel modification | Chemistry; Metallurgy | 5 | Expired |
| US7906479B2 | Sterile suspensions of slightly soluble basic peptide complexes and pharmaceutical formulations containing them | Human Necessities | 0 | Active |
| US10022328B2 | Dialkyl sulfosuccinate compositions, method of making, and method of use | Human Necessities | 0 | Active |
| US7790686B2 | Injection solution of an LHRH antagonist | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.